Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Gustafson Kurt A
Relationship:   Director
City:   San Diego
State:   CA
   
Insider Summary:
  
   
Companies Owned :   4    
Direct Shares   535,630    

Indirect Shares

  11,840      
Direct Value   $2,846,091    

Indirect Value

  $12,195      
Total Shares   547,470      
Total Value   $2,858,286      


Halozyme Therapeutics Inc
 $1,594,672 Spectrum Pharmaceuticals Inc
 $326,777 OmniAb, Inc
 $786,302 Xencor Inc
 $138,341 Halozyme Therapeutics Inc
 $1,594,672 Spectrum Pharmaceuticals Inc
 $326,777 OmniAb, Inc
 $786,302 Xencor Inc
 $138,341
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    1   
    3    

     Stock price went up :

    1   
    0    
     Stock price went down :
    0   
    3    
   
     Gain/Loss Ratio :
   1.0   
   -3.0   
     Percentage Gain/Loss :
   103.1%
 -35.2%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Halozyme Therapeutics Inc HALO Vice President and CFO 2013-02-02 35,667 2011-08-09 0    Premium*  
            Spectrum Pharmaceuticals Inc SPPI EVP & Chief Financial ... 2022-03-16 317,259 2022-03-16 11,840    Premium*  
            OmniAb, Inc OABI Executive VP, Finance ... 2024-04-08 176,697 2022-11-01 0    Premium*  
            Xencor Inc XNCR Director 2024-03-06 6,007 2023-06-20 0    Premium*  
* Premium Members only  

Records found :    64         Free Registration Required For Full Results.    Limit: 25

Download
  Page 2 of 3
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
SPPI Spectrum Pharmaceuticals ... EVP & Chief Financial Officer   •       –      –    2017-03-22 4 D $6.42 $18,098 D/D (2,819) 136,748 0 -
SPPI Spectrum Pharmaceuticals ... EVP & Chief Financial Officer   •       –      –    2017-03-25 4 D $6.61 $9,320 D/D (1,410) 135,338 0 -
SPPI Spectrum Pharmaceuticals ... EVP & Chief Financial Officer   •       –      –    2017-03-28 4 D $6.69 $31,530 D/D (4,713) 180,788 0 -
SPPI Spectrum Pharmaceuticals ... EVP & Chief Financial Officer   •       –      –    2017-03-28 4 A $0.00 $0 D/D 50,163 185,501 0 -
SPPI Spectrum Pharmaceuticals ... EVP & Chief Financial Officer   •       –      –    2017-06-03 4 D $5.96 $55,994 D/D (9,395) 171,393 0 -
SPPI Spectrum Pharmaceuticals ... EVP & Chief Financial Officer   •       –      –    2018-01-15 4 A $0.00 $0 D/D 19,445 195,483 0 -
SPPI Spectrum Pharmaceuticals ... EVP & Chief Financial Officer   •       –      –    2018-03-22 4 AS $18.13 $47,868 D/D (2,640) 192,843 0 -
SPPI Spectrum Pharmaceuticals ... EVP & Chief Financial Officer   •       –      –    2018-03-26 4 AS $17.38 $22,594 D/D (1,300) 191,543 0 -
SPPI Spectrum Pharmaceuticals ... EVP & Chief Financial Officer   •       –      –    2018-03-28 4 AS $16.35 $71,123 D/D (4,350) 187,193 0 -
SPPI Spectrum Pharmaceuticals ... EVP & Chief Financial Officer   •       –      –    2019-01-09 4 A $0.00 $0 D/D 100,326 253,795 0 -
SPPI Spectrum Pharmaceuticals ... EVP & Chief Financial Officer   •       –      –    2019-01-11 4 AS $10.87 $366,333 D/D (33,692) 220,103 0 -
SPPI Spectrum Pharmaceuticals ... EVP & Chief Financial Officer   •       –      –    2019-01-16 4 AS $10.44 $33,471 D/D (3,207) 216,896 0 -
SPPI Spectrum Pharmaceuticals ... EVP & Chief Financial Officer   •       –      –    2019-02-18 4 A $0.00 $0 D/D 40,000 256,896 0 -
SPPI Spectrum Pharmaceuticals ... EVP & Chief Financial Officer   •       –      –    2019-03-25 4 AS $9.46 $35,931 D/D (3,797) 247,640 0 -
SPPI Spectrum Pharmaceuticals ... EVP & Chief Financial Officer   •       –      –    2019-03-26 4 AS $9.90 $9,167 D/D (926) 246,714 0 -
SPPI Spectrum Pharmaceuticals ... EVP & Chief Financial Officer   •       –      –    2019-03-29 4 AS $10.65 $63,623 D/D (5,974) 240,740 0 -
SPPI Spectrum Pharmaceuticals ... EVP & Chief Financial Officer   •       –      –    2019-04-01 4 AS $10.73 $49,940 D/D (4,642) 236,098 0 -
SPPI Spectrum Pharmaceuticals ... EVP & Chief Financial Officer   •       –      –    2020-01-16 4 AS $3.37 $8,492 D/D (2,522) 233,576 0 %
SPPI Spectrum Pharmaceuticals ... EVP & Chief Financial Officer   •       –      –    2020-01-17 4 AS $3.33 $5,398 D/D (1,621) 231,955 0 %
SPPI Spectrum Pharmaceuticals ... EVP & Chief Financial Officer   •       –      –    2020-02-19 4 AS $2.77 $13,115 D/D (4,733) 208,444 0 %
SPPI Spectrum Pharmaceuticals ... EVP & Chief Financial Officer   •       –      –    2020-02-20 4 AS $2.85 $9,499 D/D (3,333) 205,111 0 %
SPPI Spectrum Pharmaceuticals ... EVP & Chief Financial Officer   •       –      –    2020-03-12 4 A $0.00 $0 D/D 163,180 368,291 0 -
SPPI Spectrum Pharmaceuticals ... EVP & Chief Financial Officer   •       –      –    2020-03-31 4 AS $2.31 $9,989 D/D (4,326) 363,965 0 %
SPPI Spectrum Pharmaceuticals ... EVP & Chief Financial Officer   •       –      –    2020-04-01 4 AS $2.23 $6,991 D/D (3,135) 360,830 0 %
SPPI Spectrum Pharmaceuticals ... EVP & Chief Financial Officer   •       –      –    2020-12-14 4 AS $5.00 $128,480 D/D (25,696) 335,134 0 %

  64  Records found
  1   2  3      
  Page 2 of 3  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed